Wegovy injections in Leeds: how they work, who they're for, and how to get them

Wegovy contains semaglutide, a GLP-1 receptor agonist that reduces appetite by mimicking a gut hormone involved in hunger signalling and gastric emptying.
The injection schedule starts at 0.25mg and is titrated by your prescriber over approximately five months up to the 2.4mg maintenance dose, and a higher 7.2mg dose is now also MHRA-approved.
In the STEP 1 clinical trial (68 weeks), participants on semaglutide 2.4mg lost an average of around 15% of their body weight, according to the STEP 1 paper published in the New England Journal of Medicine.
Common side effects are gastrointestinal (nausea, loose stools, indigestion) and are most noticeable in the early weeks or after a dose step up.

If you're in Leeds and looking into Wegovy injections, here's the direct answer: Wegovy (semaglutide 2.4mg) is a once-weekly prescription injection licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above with a weight-related health condition. It's a prescription-only medicine, which means a qualified prescriber must assess your suitability before you can start. That assessment can happen through a regulated online pharmacy — no travel to a clinic, no referral letter required — or, with significant waiting times, through NHS specialist services. What it cannot happen through is any seller offering these pens without a clinical review first.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Using Wegovy injections: the practical picture for Leeds residents

You've found the pen online, but something doesn't feel quite right

That hesitation is worth listening to. The market for weight-loss injections has attracted a significant number of sellers operating outside the law, and Leeds is no different from anywhere else in the country. The MHRA has issued repeated warnings about counterfeit semaglutide pens sold through social media and unverified websites, pens that have, in some cases, contained insulin rather than semaglutide. Large seizures of fake pens have been made across the UK, and the agency continues to flag the pattern of sellers offering these medicines without a prescription and without any clinical oversight.

The safe marker to look for is simple: a pharmacy listed on the GPhC register. Every legitimate online pharmacy dispensing prescription medicines in the UK must hold a GPhC registration, and you can verify any one of them in seconds using that public register. If a seller isn't there, don't proceed. If the price looks dramatically low, treat that as a warning rather than a deal.

For residents in Leeds who've been browsing the market, this isn't meant to alarm, it's meant to make the next step straightforward. Find a registered pharmacy, complete a proper consultation, and let a qualified prescriber assess whether Wegovy is appropriate for you. That's the process the law requires, and it exists for good reason.

What the Wegovy injection schedule actually involves day to day

Wegovy is a subcutaneous injection (meaning just under the skin) given once a week. Most people use the abdomen, thigh or upper arm, rotating the site each time to reduce local irritation. The pen is pre-filled and comes refrigerated; you'll store it in the fridge between doses, though the patient information leaflet sets out the exact room-temperature window if you need it for a day out or travel.

The titration schedule is set by your prescriber, not something to adjust yourself. Treatment opens at 0.25mg (a dose designed to let your body adjust gradually, not to produce immediate weight loss) and steps up roughly every four weeks through 0.5mg, 1.0mg and 1.7mg before reaching 2.4mg. On 14 April 2026, the MHRA also approved a dedicated 7.2mg single-dose pen for adults with a BMI of 30 or above, making it the highest available maintenance dose. Whether that's relevant to your treatment is a prescriber decision, not one to make on the basis of a search.

A useful read on how Wegovy injections work mechanically goes into the GLP-1 pathway in more depth if the science matters to you. The short version: semaglutide binds to GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing the hunger signals that drive overeating. You eat less because you're genuinely less hungry, not because you're fighting the urge.

Disposal matters too. Used pens and needles are clinical waste. A sharps container keeps disposal safe and is accepted at most community pharmacies and some GP practices.

Who Wegovy is licensed for, and where NHS access stands in Leeds

The licensed private eligibility is clear: adults with a BMI of 30 or above, or 27 to 29.9 with at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnoea and others all count). Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. A BMI that meets the threshold doesn't automatically mean approval, the prescriber's full assessment, including your health history and any contraindications, is what decides suitability.

On the NHS, semaglutide (Wegovy) is recommended by NICE under TA875 for use within specialist weight management services, for a maximum of two years, for adults with a BMI of 35 or above (or 30 to 34.9 meeting specialist referral criteria) and at least one weight-related comorbidity. For most Leeds residents that means a referral, a waiting list, and a specialist service with multidisciplinary support. Waiting times in many areas are long, and not everyone will meet the NHS threshold.

Private treatment through a regulated pharmacy is the practical alternative for people who don't meet NHS criteria or don't want to wait. It's not a workaround, it's the same licensed medicine, prescribed through the same legal framework, by a qualified prescriber. The difference is speed and access. For context on what private treatment costs and what a legitimate price should include, the weight-loss treatments page is the place to start.

Side effects, safety signals, and when to get medical help

The gastrointestinal side effects of semaglutide are well-documented and, for most people, manageable. Nausea is the most common; loose stools, constipation, burping and indigestion follow. They tend to be sharpest in the first few weeks and after dose increases, then settle. Eating smaller portions and avoiding high-fat meals during the early period helps considerably, something our prescribers mention routinely.

Pancreatitis is a less common but more serious concern. In January 2026 the MHRA issued a Drug Safety Update specifically addressing acute pancreatitis as a known risk with GLP-1 medicines: severe, persistent stomach pain spreading to your back, with or without vomiting, is the key symptom to act on immediately. Don't wait to see if it passes. Get medical help the same day.

Other signs that warrant prompt contact with a clinician: symptoms of dehydration from prolonged vomiting or diarrhoea, signs of an allergic reaction, or gallbladder pain. The MHRA Yellow Card scheme lets patients report suspected side effects directly, and doing so contributes to the ongoing safety monitoring of these medicines.

Wegovy is not recommended during pregnancy, while breastfeeding, or if you're actively trying to conceive. It's not licensed for under-18s. If you're taking an oral contraceptive pill, you should discuss this with your prescriber before starting, GLP-1 medicines can affect how the pill is absorbed, particularly in the early weeks of treatment. These aren't reasons to avoid seeking information; they're reasons to have the consultation first. You can read more about Wegovy injections in full, find out what Wegovy injections are and how they compare to other options, or if you're weighing up different treatments, our page covering weight loss injections including Ozempic explains how the options compare and where the Wegovy injection sits within that landscape, before deciding whether to take the next step. If you're specifically interested in the active ingredient itself, our guide to semaglutide injections covers how they work, what to expect, and how they're prescribed.

When you're ready, speak to our prescribers, the consultation is free, reviewed the same day by a GPhC-registered Independent Prescriber, and there's no obligation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions